Skip to content

OrthoFlex

Active
Private limited companyfounded 20197 yrs activeGemeentehuisstraat 32, 1740 Ternat, BelgiumKBO/BCE: BE 0721.409.091

OrthoFlex has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €76k and a net result of €27k. Equity remains stable across the filed fiscal years (±2% per year). Its solvency ranks better than 47% of 636 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2025
89 / 100
Excellent▲ +21 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+69
Solvency66▲+9
Growth52=
Stability100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.33 against 1.39 in 2024), and 62.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 7 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
37.7%
Return on assets
13.4%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
9 d early
2024
15 d early
2023
25 d early
2022
31 d early
2021
31 d early
2020
16 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€76k▲ 10.1%
2024 · €69k
2020: €67k 2021: €98k 2022: €112k 2023: €155k 2024: €69k
2020 → 2025
Total assets
€201k▼ 9.2%
2024 · €222k
2020: €189k 2021: €281k 2022: €221k 2023: €263k 2024: €222k
2020 → 2025
Net result
€27k▲ 524%
2024 · €4k
2020: €48k 2021: €53k 2022: €13k 2023: €44k 2024: €4k
2020 → 2025
Working capital
€40k▼ 17.2%
2024 · €49k
2020: €82k 2021: €106k 2022: €134k 2023: €161k 2024: €49k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€98k-€112k▲ 13.4%€155k▲ 39.1%€69k▼ 55.6%€76k▲ 10.1%
Operating result€66k-€22k▼ 66.9%€58k▲ 166%€9k▼ 85.2%€32k▲ 270%
Net result€53k-€13k▼ 75.2%€44k▲ 231%€4k▼ 90.1%€27k▲ 524%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60kOperating result 2021: €66k€66kNet result 2021: €53k€53kOperating result 2022: €22k€22kNet result 2022: €13k€13kOperating result 2023: €58k€58kNet result 2023: €44k€44kOperating result 2024: €9k€9kNet result 2024: €4k€4kOperating result 2025: €32k€32kNet result 2025: €27k€27k20212022202320242025
The operating result recovers in 2025; 2025 is 270% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €201k
Fixed assets €37k▼ 20.3%
Current assets €164k▼ 6.2%
Equity and liabilities €201k
Equity €76k▲ 10.1%
Debt €126k▼ 17.9%
The debt ratio falls from 68.9% to 62.3%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€44k
2024 · €18k
Cash flow
€39k
2024 · €14k
Solvency
37.7%
2024 · 31.1%
Current ratio
1.33
2024 · 1.39
Quick ratio
1.13
2024 · 1.21
Debt / equity
1.66
2024 · 2.22
ROE
35.6%
2024 · 6.3%
ROA
13.4%
2024 · 2.0%
Interest coverage
29.12
2024 · 7.53
Debt
€126k
2024 · €153k
Debt ≤ 1 year
€124k
2024 · €126k
Debt > 1 year
€2k
2024 · €6k
Income taxes
€4k
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€222k€201k
Fixed assets21/28€47k€37k
Intangible fixed assets21€3k€2k
Tangible fixed assets22/27€44k€35k
Land and buildings22€6k€5k
Plant, machinery and equipment23€16k€12k
Furniture and vehicles24€21k€18k
Financial fixed assets28€0-
Current assets29/58€175k€164k
Amounts receivable after more than one year29€0-
Other amounts receivable291€0-
Stocks and contracts in progress3€22k€25k
Stocks30/36€22k€25k
Amounts receivable within one year40/41€45k€8k
Trade receivables40€30k€3k
Other amounts receivable41€15k€6k
Cash at bank and in hand54/58€96k€112k
Deferred charges and accrued income490/1€11k€19k
Equity and liabilities
Total equity and liabilities10/49€222k€201k
Equity10/15€69k€76k
Contributions10/11€8k€8k=
Profit (loss) carried forward14€61k€68k
Amounts payable17/49€153k€126k
Amounts payable after more than one year17€6k€2k
Financial debts170/4€6k€2k
Amounts payable within one year42/48€126k€124k
Current portion of amounts payable after more than one year42€4k€4k
Trade debts44€79k€56k
Suppliers440/4€79k€56k
Taxes, remuneration and social security45€2k€2k
Taxes450/3€2k€2k
Other amounts payable47/48€41k€61k
Accrued charges and deferred income492/3€21k€145
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€12k
Other operating charges640/8€938€894
Gross operating margin9900€19k€45k
Operating profit (loss)9901€9k€32k
Financial income75/76B€68€109
Recurring financial income75€68€109
Financial charges65/66B€2k€2k
Recurring financial charges65€2k€2k
Profit (loss) for the period before taxes9903€6k€31k
Income taxes67/77€2k€4k
Profit (loss) for the period9904€4k€27k
Profit (loss) for the period to be appropriated9905€4k€27k
Appropriation of the result
Profit (loss) to be appropriated9906€61k€88k
Profit (loss) brought forward from the previous period14P€57k€61k
Profit to be distributed694/7-€20k
Directors or managers695-€20k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
22-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
16-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Weakest financial yearnet €4k ▼90.1%
Net result drops to €4k, the lowest in the series; recovery starts the following year.
06-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €150kEq €155k ▲39.1%
4 profitable years in a row build equity to €155k.
30-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €100kEq €112k ▲13.4%
3 profitable years in a row build equity to €112k.
30-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Highest result since 2020net €53k ▲9.6%
Operating result €66k, net result €53k, both a record.
15-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
no sitting director, no change since 2024
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
25-07-2024 Resigned as Director
25-07-2024 Resigned as Daily management
Location & real-estate footprint
Registered office, Ternat · 1 establishment unit since 2019
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Gemeentehuisstraat 321740 Ternat
Ground area
689 m²
Building footprint
278 m²
Volume, LiDAR
208 m³
Parcel 23086E0370/00T000, Flanders · tallest building 9.4 m. Linked by address, not a title deed.
1 establishment unit
OrthoFlex
Gemeentehuisstraat 32, 1740 TernatOther manufacturing
since 20192.285.848.055
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23086E0370/00T000 Flanders 689 m² 1 · 278 m² 9.4 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 2,112 EUR awarded · 2,112 EUR paid
Year Entries awardedpaid
2023 1 1,261 EUR1,261 EUR
2022 1 851 EUR851 EUR
Schemes
Hulpmiddelen voor personen met een beperkte mobiliteit
2 entries · 2,112 EUR · 2,112 EUR paid · AGENTSCHAP VLAAMSE SOCIALE BESCHERMING

Recognitions · licences · registrations

Care and welfare

1 service
OrthoFlex
Care and Health agency · live

Similar companies · same sector, comparable size

Of 1,245 companies in sector 32500 we hold annual accounts for 692. 513 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded21-02-2019
Fiscal year end31-12
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
46460Wholesale of pharmaceutical and medical goods
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.